# Gandeeva Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gandeeva-therapeutics

- Industry: Biotechnology
- Headquarters: Vancouver, Canada
- Website: www.gandeeva.com
- Total disclosed funding: $40M
- Latest round: Series A (Jan 13, 2022)
- Investors on record: 6

## About

Founded in 2021 and based in Vancouver, Canada, Gandeeva Therapeutics, Inc. operates as a biotechnology company that develops novel therapeutics through the use of cryogenic electron microscopy (cryo-EM) and machine learning.

In 2021, the company was founded by Sriram Subramaniam, a medical expert that revolutionised the cryo-EM, also known as cryo-electron microscopy, method in clinical usage. He also has contribution to the study of HIV-1, influenza, and related viruses for vaccine development, and in focused ion beam technologies for cell and tissue imaging.

Gandeeva develop pharmaceuticals via its AI-driven platforms -- SPOTLIGHT, HYPERFOCUS, CRYO-CADD -- all of which are engines that can help with drug develop process. SPOTLIGHT is the hit product that can visualise measure and capture protein-protein and protein-drug interactions to target disease-relevant proteins and influence their function.

## Funding rounds

- Series A, Jan 13, 2022, $40M — Amgen Ventures, Lux Capital, Obvious, Amplitude, Air Street Capital, Leaps by Bayer

## Investors

- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series A
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Series A
- Obvious (https://capitalatlas.ai/funds/obvious) — Series A
- Amplitude (https://capitalatlas.ai/funds/amplitude) — Series A
- Air Street Capital (https://capitalatlas.ai/funds/air-street-capital) — Series A
- Leaps by Bayer (https://capitalatlas.ai/funds/leaps-by-bayer) — Series A